136941-70-3
中文名稱 | 136941-70-3 |
---|---|
中文同義詞 | 化合物 T10101;鈣離子通道調(diào)節(jié)劑1;鈣離子通道調(diào)節(jié)劑1,10 MM DMSO 溶液 |
英文名稱 | 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, methyl 3-(3-oxo-1,2-benzisothiazol-2(3H)-yl)propyl ester, S,S-dioxide |
英文同義詞 | 3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, methyl 3-(3-oxo-1,2-benzisothiazol-2(3H)-yl)propyl ester, S,S-dioxide;Calcium channel-modulator-1;3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-[3-(1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)propyl] 5-methyl ester;Calcium channelmodulator1,Calcium channel modulator 1;Calcium channel-modulator-1, 10 mM in DMSO |
CAS號 | 136941-70-3 |
分子式 | C26H24Cl2N2O7S |
分子量 | 579.44896 |
EINECS號 | |
相關類別 | |
Mol文件 | 136941-70-3.mol |
結構式 | ![]() |
136941-70-3 性質(zhì)
沸點 | 721.2±70.0 °C(Predicted) |
---|---|
密度 | 1.427±0.06 g/cm3(Predicted) |
儲存條件 | Store at -20°C |
溶解度 | 溶于二甲基亞砜 |
形態(tài) | 固體 |
酸度系數(shù)(pKa) | 2.62±0.70(Predicted) |
顏色 | 白色至米白色 |
IC50: 0.8 μM (Aortic contraction)
Oral administration of Calcium channel-modulator-1 (20 mg/kg) causes a 35-37% decrease in systolic blood pressure in spontaneously hypertensive rats. However, iv administration of Calcium channel-modulator-1 to anesthetized spontaneously hypertensive rats causes a decrease in blood pressure which was more pronounced and long-lasting than that of nifedipine.
安全信息
更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
---|---|---|---|---|---|
2025/05/22 | HY-U00135 | Calcium channel-modulator-1 | 136941-70-3 | 1 mg | 1530元 |
2025/05/22 | HY-U00135 | 136941-70-3 Calcium channel-modulator-1 | 136941-70-3 | 5 mg | 2970元 |